RE:RE:RE:I Found This Interesting...Brossard, Quebec, Canada – September 19th, 2017 - DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK, OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a development of new cardiovascular risk score, that will enable the early detection of this critical disease by its CARA platform. The calibration of our application will be done simultaneously in 4 countries with a minimum of 1,000 in each country with the support of 22 cardiologists. This will enable us to insure the sustainability of our solution worldwide. The partners that will be collaborating with DIAGNOS are in Algeria, Canada, Mexico and United States. “We’re at the final development stage and ready to evaluate the effectiveness of our automatic grading for the new risk score test CARA Cardio. Continually, we hear from physicians and health insurers that our screening tests are very much needed to detect at early stage the cardiovascular anomalies. Our preventive cardiovascular risk score test will be used to prospectively predict and monitor the cardiovascular artery diseases. Diagnos’ AI will automatically grade the retinal microcirculation state to generate this score. At regular interval, we will monitor the patients using the same test” said Dr Hadi Chakor, Diagnos Chief Medical Officer. “Our test will precede painful and stressing invasive procedure that may cause costly late complication.”